These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22933251)

  • 1. Brief report: adrenal autoimmunity in primary Sjögren's syndrome.
    Mavragani CP; Schini M; Gravani F; Kaltsas G; Moutsopoulos HM
    Arthritis Rheum; 2012 Dec; 64(12):4066-71. PubMed ID: 22933251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine alterations in primary Sjogren's syndrome: an overview.
    Mavragani CP; Fragoulis GE; Moutsopoulos HM
    J Autoimmun; 2012 Dec; 39(4):354-8. PubMed ID: 22695186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune thyroiditis and primary Sjögren's syndrome: clinical and laboratory evidence of the coexistence of the two diseases.
    Hansen BU; Ericsson UB; Henricsson V; Larsson A; Manthorpe R; Warfvinge G
    Clin Exp Rheumatol; 1991; 9(2):137-41. PubMed ID: 2060160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated IgG4 serum levels among primary Sjögren's syndrome patients: do they unmask underlying IgG4-related disease?
    Mavragani CP; Fragoulis GE; Rontogianni D; Kanariou M; Moutsopoulos HM
    Arthritis Care Res (Hoboken); 2014 May; 66(5):773-7. PubMed ID: 25100215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of interleukin-7 in labial salivary glands of patients with primary Sjögren's syndrome correlates with increased inflammation.
    Bikker A; van Woerkom JM; Kruize AA; Wenting-van Wijk M; de Jager W; Bijlsma JW; Lafeber FP; van Roon JA
    Arthritis Rheum; 2010 Apr; 62(4):969-77. PubMed ID: 20131250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of interferon-λ in minor salivary glands of patients with primary Sjögren's syndrome and its synergic effect with interferon-α on salivary gland epithelial cells.
    Ha YJ; Choi YS; Kang EH; Chung JH; Cha S; Song YW; Lee YJ
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):31-40. PubMed ID: 28421993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome.
    Ittah M; Miceli-Richard C; Eric Gottenberg J; Lavie F; Lazure T; Ba N; Sellam J; Lepajolec C; Mariette X
    Arthritis Res Ther; 2006; 8(2):R51. PubMed ID: 16507175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of subclinical Sjögren's syndrome features in patients with autoimmune thyroid disease.
    Coll J; Anglada J; Tomas S; Reth P; Goday A; Millan M; Pujol-Borrell R; Corominas J
    J Rheumatol; 1997 Sep; 24(9):1719-24. PubMed ID: 9292794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of autoimmunity to REG, a regeneration factor, in patients with primary Sjögren's syndrome.
    Yoshimoto K; Fujimoto T; Itaya-Hironaka A; Miyaoka T; Sakuramoto-Tsuchida S; Yamauchi A; Takeda M; Kasai T; Nakagawara K; Nonomura A; Takasawa S
    Clin Exp Immunol; 2013 Oct; 174(1):1-9. PubMed ID: 23701206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-centromere antibody-positive Sjögren's syndrome: A distinct clinical subgroup?
    Lee KE; Kang JH; Lee JW; Wen L; Park DJ; Kim TJ; Park YW; Lee SS
    Int J Rheum Dis; 2015 Sep; 18(7):776-82. PubMed ID: 26179502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rates of infiltration by macrophages and dendritic cells and expression of interleukin-18 and interleukin-12 in the chronic inflammatory lesions of Sjögren's syndrome: correlation with certain features of immune hyperactivity and factors associated with high risk of lymphoma development.
    Manoussakis MN; Boiu S; Korkolopoulou P; Kapsogeorgou EK; Kavantzas N; Ziakas P; Patsouris E; Moutsopoulos HM
    Arthritis Rheum; 2007 Dec; 56(12):3977-88. PubMed ID: 18050195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatigue in Primary Sjögren's Syndrome: Clinical, Laboratory, Psychometric, and Biologic Associations.
    Karageorgas T; Fragioudaki S; Nezos A; Karaiskos D; Moutsopoulos HM; Mavragani CP
    Arthritis Care Res (Hoboken); 2016 Jan; 68(1):123-31. PubMed ID: 26315379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren's syndrome.
    Lavie F; Miceli-Richard C; Quillard J; Roux S; Leclerc P; Mariette X
    J Pathol; 2004 Apr; 202(4):496-502. PubMed ID: 15095277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between primary Sjögren's syndrome and autoimmune thyroid disease].
    Kohriyama K; Katayama Y; Tsurusako Y
    Nihon Rinsho; 1999 Aug; 57(8):1878-81. PubMed ID: 10483269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticentromere antibodies identify patients with Sjögren's syndrome and autoimmune overlap syndrome.
    Salliot C; Gottenberg JE; Bengoufa D; Desmoulins F; Miceli-Richard C; Mariette X
    J Rheumatol; 2007 Nov; 34(11):2253-8. PubMed ID: 17937465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of BAFF and IL-17A with subphenotypes of primary Sjögren's syndrome.
    Deng F; Chen J; Zheng J; Chen Y; Huang R; Yin J; Gao X; Lin Q; Huang C; Gao Y; Yu X; Liu Z
    Int J Rheum Dis; 2016 Jul; 19(7):715-20. PubMed ID: 25941062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the type I interferon system in primary Sjögren's syndrome: a possible etiopathogenic mechanism.
    Båve U; Nordmark G; Lövgren T; Rönnelid J; Cajander S; Eloranta ML; Alm GV; Rönnblom L
    Arthritis Rheum; 2005 Apr; 52(4):1185-95. PubMed ID: 15818675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune thyroiditis and anti-thyroid antibodies in primary Sjogren's syndrome: a case-control study.
    Tunc R; Gonen MS; Acbay O; Hamuryudan V; Yazici H
    Ann Rheum Dis; 2004 May; 63(5):575-7. PubMed ID: 15082490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association of systemic lupus erythematosus and Sjögren's syndrome].
    Szántó A; Kiss E; Sas A; Szegedi G; Zeher M
    Orv Hetil; 2005 Dec; 146(50):2533-8. PubMed ID: 16440498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type I and II interferon signatures in Sjogren's syndrome pathogenesis: Contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesis.
    Nezos A; Gravani F; Tassidou A; Kapsogeorgou EK; Voulgarelis M; Koutsilieris M; Crow MK; Mavragani CP
    J Autoimmun; 2015 Sep; 63():47-58. PubMed ID: 26183766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.